LITAF has been demonstrated to play an important role in rheumatoid arthritis, Crohn's disease, innate immune dysregulation in the central nervous system and inflammatory changes in mesenteric fat linked to metabolic syndrome in obesity and insulin resistance [26]. Here, LITAF is linked to Crohn disease.